| the promoter activity of myeloproliferative leukemia virus oncogene is modulated by transcription through a PKC-dependent pathway | leukemia, |
| Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms. | neoplasm, |
| Lack of c-mpl proto-oncogene transcripts and growth-stimulatory effects of thrombopoietin on human small cell lung cancer cell lines. | lung, |
| Modulation of human c-mpl gene expression by thrombopoietin through protein kinase C. | None |
| Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. | None |
| The oncogene V-MPL, a putative truncated cytokine receptor which immortalizes hematopoietic progenitors. | None |
| it was concluded that the oncogenic event in idiopathic myelofibrosis associated with the MPLW515L/K mutations probably occurs in a progenitor cell common to both myeloid and lymphoid cells, such as the pluripotent haematopoietic stem cell | None |
| MPL 515 and JAK2 mutation analysis in MDS presenting with a platelet count of more than 500 x 10(9)/l. | None |
| Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. | None |
| Hypomethylation mediated by decreased DNMTs involves in the activation of proto-oncogene MPL in TK6 cells treated with hydroquinone. | None |
| His(499) regulates the activation of human TpoR and provides additional protection against activating mutations, such as oncogenic Asn mutations in the TM domain | None |
| From the v-mpl oncogene to thrombopoietin. | None |
| Expression of the c-mpl proto-oncogene in human hematologic malignancies. | None |
| Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. | None |
| Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. | None |
| Thrombopoietin and its receptor, the proto-oncogene c-mpl. | None |